23-valent pneumococcal polysaccharide vaccine (pneumovax-23) Report issue

Active Ingredient History

NOW
  • Now
Pneumococcal polysaccharide vaccine (PPSV)—known as Pneumovax 23 (PPV-23)—is the first pneumococcal vaccine derived from a capsular polysaccharide.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
1,2,4-trichloro-5-((4-chlorophenyl)sulfinyl)benzene | 23-valent pneumococcal capsular polysaccharide vaccine | 23-valent pneumococcal polysaccharide vaccine | 23-valent ppv | 23-valent vaccine | 2,4,5,4'-tetrachlorodiphenylsulfoxide | pneumo23 | pneumo 23 | pneumo-23 | pneumococcal 23 valent polysaccharide vaccine | pneumococcal polysaccharide vaccine | pneumococcal vaccine, polyvalent | pneumococcal vaccine, polyvalent 23 | pneumovax | pneumovax 23 | pneumovax-23 | pneumovax ii | pnu-imune 23 | polysaccharide anti- pneumococcal vaccine | ppsv23 | ppv-23 | prodiax-23 | tetanus toxoid [tt]-containing adsorbed vaccine | v110

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue